AU7052291A - Genetic protection of animals against infection by the bovine leukemia virus, and provirus and recombinant virus derived from this virus - Google Patents

Genetic protection of animals against infection by the bovine leukemia virus, and provirus and recombinant virus derived from this virus

Info

Publication number
AU7052291A
AU7052291A AU70522/91A AU7052291A AU7052291A AU 7052291 A AU7052291 A AU 7052291A AU 70522/91 A AU70522/91 A AU 70522/91A AU 7052291 A AU7052291 A AU 7052291A AU 7052291 A AU7052291 A AU 7052291A
Authority
AU
Australia
Prior art keywords
virus
provirus
against infection
derived
animals against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70522/91A
Inventor
Claude Delouis
Denis Milan
Jean-Francois Nicolas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Institut National de la Recherche Agronomique INRA
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of AU7052291A publication Critical patent/AU7052291A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU70522/91A 1989-12-20 1990-12-20 Genetic protection of animals against infection by the bovine leukemia virus, and provirus and recombinant virus derived from this virus Abandoned AU7052291A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8916929A FR2655855B1 (en) 1989-12-20 1989-12-20 GENETIC PROTECTION OF ANIMALS AGAINST INFECTION WITH THE BOVINE LEUCEMOGEN VIRUS, AND PROVIRUS AND RECOMBINANT VIRUS DERIVED FROM THIS VIRUS.
FR8916929 1989-12-20

Publications (1)

Publication Number Publication Date
AU7052291A true AU7052291A (en) 1991-07-18

Family

ID=9388777

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70522/91A Abandoned AU7052291A (en) 1989-12-20 1990-12-20 Genetic protection of animals against infection by the bovine leukemia virus, and provirus and recombinant virus derived from this virus

Country Status (3)

Country Link
AU (1) AU7052291A (en)
FR (1) FR2655855B1 (en)
WO (1) WO1991009116A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9520641D0 (en) * 1995-10-10 1995-12-13 Medical Res Council Improvements in or relating to protection against intracellular infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2606030B1 (en) * 1986-10-31 1989-10-20 Pasteur Institut DEFECTIVE RECOMBINANT RETROVIRUSES, MANUFACTURING METHOD THEREOF AND APPLICATIONS THEREOF, PARTICULARLY FOR STUDYING THE INTERACTION OF WILD RETROVIRUSES WITH CELL LINES INFECTIBLE THEREWITH
JPH02502425A (en) * 1987-03-09 1990-08-09 ジ・アップジョン・カンパニー Transgenic animal cells resistant to viral infection
WO1989005349A1 (en) * 1987-12-09 1989-06-15 The Australian National University Method of combating viral infections
JPH03504079A (en) * 1988-03-21 1991-09-12 カイロン　コーポレイション recombinant retrovirus

Also Published As

Publication number Publication date
FR2655855B1 (en) 1992-04-10
FR2655855A1 (en) 1991-06-21
WO1991009116A1 (en) 1991-06-27

Similar Documents

Publication Publication Date Title
AU1628895A (en) Recombinant virus
AU7246687A (en) 5-arylalkyl-4-alkoxy-2(5H)-furanones, intermediates and processes for the preparation thereof and medicaments containing them
AU2445888A (en) Recombinant fowlpox virus, vectors for the expression of heterologous proteins and vaccines for poultry derived from this virus
AU9156291A (en) Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs
AU4653989A (en) Biologically competent, virus inactivated albumin
ATA902590A (en) RECOMBINANT SMALL VIRUS
AU3636189A (en) Hiv-2 virus variants
AU625328B2 (en) Recombinant varicella-zoster glycoproteins and their derivatives
AU1632392A (en) Recombinant avipox virus, the culture of cells infected with this virus and vaccines for poultry derived from this virus
EP0584558A3 (en) A composition for suppressing infection and growth of human immunodeficiency virus using an iron-binding protein.
CA2185541A1 (en) Cytotoxic t-cell epitopes
AU570328B2 (en) Solid medicament formulations containing dihydropyridines
OA09427A (en) "Viral treatment system".
EP0525828A3 (en) Recombinant polypeptides and their uses, including assay for aids virus
AU3961793A (en) Virus resistant plants
AU7691191A (en) Recombinant spider silk proteins through genetic engineering
WO1990013281A3 (en) Method of suppressing hiv infection
AU2520692A (en) Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus
AU7052291A (en) Genetic protection of animals against infection by the bovine leukemia virus, and provirus and recombinant virus derived from this virus
IL106591A0 (en) An interferon alpha/beta binding protein,its preparation and pharmaceutical compositions containing it
AU5836390A (en) Human lymphoma-associated virus
CA2141951A1 (en) Inhibition of retrovirus infection
AU8976691A (en) Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof
AU2542888A (en) Low molecular weight xylanase glycoprotein
EP0244427A4 (en) Recombinant virus.